Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.57 +0.01 (+1.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Rani Therapeutics Holdings (RANI) Other Accumulated Expenses (2020 - 2026)

Updated

Rani Therapeutics Holdings' Other Accumulated Expenses came in at $931,000 for Q4 2024, up 86.2% from $500,000 a year earlier.

Analysis

Rani Therapeutics Holdings (RANI) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

  • Going back by year, Other Accumulated Expenses was $500,000 in FY2023 (+624.6%) and $69,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Rani Therapeutics Holdings 111.44 Mn -41.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 45,000.00
Jun 30, 2026 67,000.00
Mar 31, 2026 97,000.00
Dec 31, 2025 46,000.00
Dec 31, 2024 283,000.00
Dec 31, 2023 254.00
Dec 31, 2022 53,000.00
Sep 30, 2022 55,000.00
Jun 30, 2022 30,000.00
Mar 31, 2022 140,000.00
Dec 31, 2021 126,000.00
Sep 30, 2021 290,000.00
Jun 30, 2021 883,000.00
Dec 31, 2020 145,000.00
API Access

Rani Therapeutics Holdings Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RANI&period=max&api_key=YOUR_API_KEY